PRIME THERAPEUTICS

Pharmacy Benefit Management

Filings
77
Clients
1
Total Income
—
Years Active
2008–2026

Filings

Year Client Period Income Expenses Doc
2026 PRIME THERAPEUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
— $100,000
2026 PRIME THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $120,000
2025 PRIME THERAPEUTICS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
— $100,000
2025 PRIME THERAPEUTICS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
— $100,000
2025 PRIME THERAPEUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
— $100,000
2025 PRIME THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $420,000
2024 PRIME THERAPEUTICS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
— $100,000
2024 PRIME THERAPEUTICS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
— $100,000
2024 PRIME THERAPEUTICS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
— $100,000
2024 PRIME THERAPEUTICS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
— $90,000
Page 1 of 8  ·  77 filings Next

Clients Represented

ClientFilingsTotal Income
PRIME THERAPEUTICS 77 —

Lobbyists

NameDisclosed Prior Position
JULIE CAROL CANTOR-WEINBERG
STACEY FAHRNER VP Government Affairs
DAVID ROOT
JERRY STEFFL